Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nitco Ltd. Capital/Financing Update 2025

Apr 16, 2025

62410_rns_2025-04-16_67ad6dbe-2787-4a21-aa15-8b42ff62cfaa.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [157 x 66] intentionally omitted <==

NITCO/SE/2025-26/02 April 16, 2025

To,

Corporate Service Department
BSE Limited
Jeejeebhoy Towers
Dalal Street,
Mumbai – 400 001
Script code:532722
The Listing Department
National Stock Exchange of India Limited
Exchange Plaza, Bandra Kurla Complex, Bandra
(E),
Mumbai – 400 051
Script code:NITCO

Dear Sir/Madam,

Sub: Intimation of receipt of In - Principle approval for listing of 15,68,63,000 equity shares of - Rs. 10 / issued on Preferential Basis from National Stock Exchange of India Limited and BSE Limited

We wish to inform you that National Stock Exchange of India Limited vide letter no. NSE/LIST/47186 dated April 03, 2025 and BSE Limited vide letter no. LOD/PREF/MV/FIP/58/2025-28 dated April 15, 2025 has granted In-principle approval for Listing of 15,68,63,000 equity shares of Rs. 10/- each allotted to promoter & non-promoters on a preferential basis.

The details required pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated July 13, 2023 are enclosed as Annexure A.

Kindly take the above information on records.

Thanking You,

Yours Sincerely,

For NITCO Limited

Digitally signed by VIVEK VIVEK PRANNATH PRANNATH TALWAR TALWAR Date: 2025.04.16 16:34:23 +05'30'


Vivek Talwar Chairman & Managing Director DIN: 00043180 Encl: a/a

Registered Office: NITCO Limited, 3/A, Recondo Compound, Sudam Kalu Ahire Marg, Glaxo, Worli Colony, Mumbai, Maharashtra, India, 400 030. Tel.: 91-22-25772800|25772790. CIN: L26920MH1966PLC016547. Email: [email protected] Website: www. nitco.in

==> picture [157 x 66] intentionally omitted <==

Annexure A

The details as required to be disclosed under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are as follows

Sr.No Particulars Details
1. name of the regulatory or licensing
authority;
National Stock Exchange of India
Limited (NSE) & BSE Limited (BSE)
2. brief details of the approval/license
obtained/ withdrawn/ surrendered;
In – Principle approval granted by
NSE
and
BSE
for
Listing
of
15,68,63,000 Equity shares of Rs. 10/-
each issued onpreferential basis.
3. impact/relevance
of
such
approval/license to the listed entity;
Upon receipt of In - Principle
approvals, the Company is permitted
to list 15,68,63,000 equity shares of Rs.
10/- each on NSE & BSE.
4. withdrawal/cancellation or suspension
of license/approval by the regulatory or
licensing authority, with reasons for such
action, estimated impact (monetary or
otherwise) on the listed entity and
penalty, if any;
Not Applicable
5. period for which such approval/license
is/was valid;
As per the timelines stated in the
approval letters
6. The
actual
impact
(monetary
or
otherwise) along with corrective actions
taken by the listed entity pursuant to the
withdrawal, cancellation or suspension of
the keylicense/approval
Not Applicable

Registered Office: NITCO Limited, 3/A, Recondo Compound, Sudam Kalu Ahire Marg, Glaxo, Worli Colony, Mumbai, Maharashtra, India, 400 030. Tel.: 91-22-25772800|25772790. CIN: L26920MH1966PLC016547. Email: [email protected] Website: www. nitco.in